Get started
Author

Carissa C. Jones

Observed names: C. Jones, Carissa C Jones, Carissa Jones
Institution: Sarah Cannon
ORCID: 0009-0001-1637-9786
Observed ORCID: 0009-0001-1637-9786
OpenAlex ID: A5110573233
Racial Disparities in Lung Cancer Survival: The Contribution of Stage, Treatment, and Ancestry
2018 · Carissa C. Jones, Sarah Fletcher Mercaldo, et al. · Journal of Thoracic Oncology · 53
PDF
Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings
2022 · Emma G Sturgill, Amanda Misch, et al. · The Oncologist · 31
PDF
Next-Generation Sequencing of Patients With Breast Cancer in Community Oncology Clinics
2021 · Emma G. Sturgill, Amanda Misch, et al. · JCO Precision Oncology · 17
Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans
2019 · Carissa C. Jones, Yuki Bradford, et al. · Cancer Epidemiology Biomarkers & Prevention · 16
PDF
Discovery of Novel Putative Inhibitors of UDP-GlcNAc 2-Epimerase as Potent Antibacterial Agents
2013 · Yong Xu, Benjamin Brenning, et al. · ACS Medicinal Chemistry Letters · 12
Genetic variation in the eicosanoid pathway is associated with non-small-cell lung cancer (NSCLC) survival
2017 · Lindsay N. Sausville, Carissa C. Jones, et al. · PLoS ONE · 10
PDF
Germline Genetic Variants and Lung Cancer Survival in African Americans
2017 · Carissa C. Jones, William S. Bush, et al. · Cancer Epidemiology Biomarkers & Prevention · 8
De novo EGFR T790M mutations in a community-based oncology practice.
2022 · Marilyn Elaine Holt, Amanda Misch, et al. · Journal of Clinical Oncology · 4
Clinical and genomic analysis of non-small cell lung cancer (NSCLC) patients with MET exon14 skipping (METex14) mutations and responses to anti-MET therapy.
2020 · Andrew McKenzie, Arielle Fisher, et al. · Journal of Clinical Oncology · 4
Concordance of blood and tissue TMB from NGS testing in real-world settings and their ability to predict response to immunotherapy.
2021 · Emma Sturgill, Amanda Misch, et al. · Journal of Clinical Oncology · 3
Preclinical Characterization of the JAK-2 Inhibitor, SGI-1252
2008 · Kausar Begam Riaz Ahmed, Roberto H Nussenzveig, et al. · Blood · 3
Clinical and molecular presentation of KRAS G12D-mutated pancreatic ductal adenocarcinoma in real-world settings.
2023 · Emma G. Sturgill, Sahiti Kolli, et al. · Journal of Clinical Oncology · 1
PDF
Implementation of a virtual, on-demand, molecular tumor board at a large, multi-clinic, community oncology practice.
2022 · Andrew Jacob McKenzie, Carissa Jones, et al. · Journal of Clinical Oncology · 1
Abstract A190: In vivo activity of SGI-110, a novel hypomethylating agent for treatment in hematology and solid malignancies
2009 · Jason Scholl, David Vollmer, et al. · Molecular Cancer Therapeutics · 1
Abstract C206: In vivo activity of SGI-1252, a potent, small-molecule dual inhibitor of JAK2 and ALK2
2009 · Vollmer David, Jared Bearss, et al. · Molecular Cancer Therapeutics · 1
Integration of a virtual personalized medicine review board integration into a major community oncology phase 1 unit.
2025 · Marilyn Elaine Hammer, Ben C. Coleman, et al. · Journal of Clinical Oncology
PDF
16P Molecular landscape of patients (pts) with metastatic breast cancer (mBC) who progressed on second-line (2L) selective estrogen receptor degraders (SERDs)
2025 · M. Hammer, E. Jaeger, et al. · ESMO Open
PDF
Supplementary Tables 1-7 and Figures 1-5 from Germline Genetic Variants and Lung Cancer Survival in African Americans
2023 · Carissa C. Jones, William S. Bush, et al.
PDF
Data from Germline Genetic Variants and Lung Cancer Survival in African Americans
2023 · Carissa C. Jones, William S. Bush, et al.
Data from Germline Genetic Variants and Lung Cancer Survival in African Americans
2023 · Carissa C. Jones, William S. Bush, et al.
Supplementary Tables 1-7 and Figures 1-5 from Germline Genetic Variants and Lung Cancer Survival in African Americans
2023 · Carissa C. Jones, William S. Bush, et al.
Early-onset colorectal cancer: Real-world genomic data from the community-based Sarah Cannon Cancer Centers Network.
2022 · Elisa Fontana, Carissa Jones, et al. · Journal of Clinical Oncology
54. Concordance of blood and tissue TMB from real-world NGS testing and their ties to immunotherapy response
2022 · Emma Sturgill, Amanda Misch, et al. · Cancer Genetics
Impact of immune checkpoint inhibitor (CPI) and EGFR tyrosine kinase inhibitor (TKI) sequence on time to treatment failure (TTF) among EGFR plus NSCLC treated in a community-based cancer research network.
2021 · Carissa Jones, Rebecca Lachs, et al. · Journal of Clinical Oncology
Abstract PS18-34: Physician adoption and molecular landscape of next-generation sequencing in breast cancer patients from community-based clinics
2021 · Emma Sturgill, Amanda Misch, et al. · Cancer Research
Works count: 29
Citation count: 165
H-index: 7
I10-index: 6
Year
Topic
Type